October 18, 2016
A simple drug used for more than 100 years is suddenly generating litigation, an international trade fight and fiery exchanges before the U.S. Food and Drug Administration, placing the spotlight on a controversial FDA program for previously unapproved drugs and teeing up the next big price increase for an inexpensive medication.